Teva Pharmaceutical Indus Ownership & Insider Activity

Teva Pharmaceutical Indus (TEVA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.6% of shares outstanding. Institutional investors hold 23.9%. Over the past 90 days, insiders made 5 sales worth $15.5M.

Shares Outstanding

1.166B

Shares Float

1.160B

Insider Shares Owned

7.513M

Insider % Owned

0.6%

Institutional Shares Held

278.507M

Institutional % Held

23.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$15.5M total

Net Activity

Net Selling

Net Value (90d)

-$15.5M

Teva Pharmaceutical Indus Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 18, 2026	Brian Savage	INTERIM CHIEF LEGAL OFFICER	SELL	2.839K	$36.77	$129K
Sep 18, 2026	Roberto Mignone	—	SELL	367.600K	$39.06	$14.4M
Aug 21, 2026	Amir Weiss	CHIEF ACCOUNTING OFFICER	SELL	6.945K	$28.61	$306K
Aug 21, 2026	Ronit Satchi-Fainaro	—	SELL	415.000	$37.25	$15K
Aug 17, 2026	Evan Lippman	EVP, BUSINESS DEVELOPMENT	SELL	18.600K	$36.57	$680K
Aug 5, 2026	Tal Zvi Zaks	—	SELL	17.000	$34.87	$593
Aug 3, 2026	Placid Jover	SEE "REMARKS"	SELL-OPTIONS	—	$34.88	$447K
Aug 3, 2026	Eric A Hughes	SEE "REMARKS"	SELL-OPTIONS	27.166K	$34.88	$892K
Jun 18, 2026	Matthew Shields	EVP, GLOBAL OPERATIONS	SELL	9.989K	$32.19	$322K
Jun 11, 2026	Eliyahu Sharon Kalif	EVP, CHIEF FINANCIAL OFFICER	SELL	106.563K	$34.10	$3.6M
Jun 5, 2026	Richard D Francis	PRESIDENT AND CEO	SELL-OPTIONS	6.890K	$34.35	$211K
Jun 3, 2026	Matthew Shields	EVP, GLOBAL OPERATIONS	SELL-OPTIONS	—	$32.87	$532K
May 14, 2026	Evan Lippman	EVP, BUSINESS DEVELOPMENT	SELL-OPTIONS	44.191K	$35.58	$1.5M
May 14, 2026	Eliyahu Sharon Kalif	EVP, CHIEF FINANCIAL OFFICER	SELL	153.251K	$35.61	$5.5M
May 6, 2026	Amir Weiss	CHIEF ACCOUNTING OFFICER	SELL	10.679K	$36.00	$384K

Date	Member	Party	Chamber	Action	Amount
Mar 30, 2026	Alan Armstrong	R	Senate	Purchase	$1,001 - $15,000